Daniel Geschwind, M.D., Ph.D.
Principal Investigator, Project 4: Refining Transcriptional Networks in MIA
Gordon and Virginia Macdonald Distinguished Professor
Principal Investigator, Project 4: Refining Transcriptional Networks in MIA
Gordon and Virginia Macdonald Distinguished Professor
Senior Associate Dean and Associate Vice Chancellor of Precision Health in the UCLA Health System and David Geffen School of Medicine
Director, UCLA Center for Autism Research and Treatment (CART)
Dr. Daniel Geschwind has focused on integrating genetics and genomics with basic neurobiology to develop a more systematic understanding of neurodevelopmental and neurodegenerative conditions. This includes efforts in the genetics of neurodevelopmental disorders involving human higher cognition, such as language, focusing on autism spectrum disorders (ASD) since 2001. He is the Principal Investigator of Project 4.
Dr. Geschwind has made developing shared scientific resources for genetic research and finding autism risk genes a major priority, and played a leading scientific role in the development of the Autism Genetic Resource Exchange. His laboratory has worked to begin to successfully connect genetic risk for disease to brain circuitry and molecular function both in humans, and in vitro and in vivo model systems. One key aspect of the effort has been the application of functional genomics to complex CNS disease, as well as the development and application of new analytic methods that elucidate the underlying network organization in multi-dimensional data.